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Abstract  22 
Objectives The increased demand for animal blood transfusions creates the need for an 23 
adequate number of donors. At the same time, a high level of blood safety must be 24 
guaranteed and different guidelines (GLs) deal with this topic. The aim of this study 25 
was to evaluate the appropriateness of different GLs in preventing transfusion-26 
transmissible infections (TTI) in Italian feline blood donors. 27 
Methods Blood samples were collected from 31 cats enrolled as blood donors by the 28 
owners’ voluntary choice over a period of approximately 1 year. Possible risk factors 29 
for TTI were recorded. Based on Italian, European and American GLs, specific TTI, 30 
including haemoplasmas, feline leukemia virus (FeLV), feline immunodeficiency virus 31 
(FIV), Anaplasma phagocytophilum, Ehrlichia spp., Bartonella spp., Babesia spp., 32 
Theileria spp., Cytauxzoon spp., Leishmania donovani sensu lato and feline coronavirus 33 
(FCoV) were screened. Rapid antigen and serological tests and biomolecular 34 
investigations (PCR) were used. Several PCR protocols for haemoplasma and FeLV 35 
DNA were compared to each other. 36 
Results The presence of at least one recognized risk factor for TTI was reported in all 37 
cats. Results for FIV and FeLV infections were negative using rapid tests, whereas 5 38 
(16.1%) cats were positive for FCoV antibodies. Four (12.9%) cats were PCR positive 39 
for haemoplasma DNA and 1 (3.2%) for FeLV provirus, the latter being positive only 40 
using the most sensitive PCR protocol applied. Other TTI were not detected using PCR. 41 
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Conclusion and relevance Blood safety increases by combining the recommendations of 42 
different GLs. To reduce the risk of TTI, sensitive tests are needed and the choice of the 43 
best protocol is a critical step in improving blood safety. The cost and time of the 44 
screening procedures may be reduced if appropriate tests are selected. To this end, the 45 
GLs should include appropriate recruitment protocols and questionnaire-based risk 46 
profiles to identify suitable donors. 47 
48 
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Introduction  49 
Recently, the increase of the indications for the veterinary blood transfusion and its 50 
routine use in the veterinary practice caused a rise in the demand for animal donors, At 51 
the same time, a high level of blood safety must be guaranteed to perform this 52 
procedure.  53 
 Transfusion-transmitted infections (TTI) from apparently healthy and asymptomatic 54 
blood donors represent a well-known threat in blood transfusion, in addition to other 55 
adverse events.1-4 Therefore, the identification of risk factors and characteristics of “low 56 
risk” blood donors are very important for increasing blood safety. Appropriate 57 
recruitment strategies could also reduce infection risks. In human medicine, the World 58 
Health Organization (WHO) identified regular voluntary non-remunerated donors as 59 
those with the lowest risk for TTI.5 However, this model cannot be used because 60 
different situations and settings exist in veterinary medicine. In cats, different 61 
prevalences of microorganisms were found based on the source of the feline donors: a 62 
previous study found that laboratory-reared cats and cats housed indoor with no history 63 
of flea or tick infestation were ideal blood donors.6 64 
Moreover, strategies and procedures ensuring blood safety for TTI change in different 65 
settings.7 For humans, it is well known that each country has to address specific issues 66 
or constraints that influence the safety of its blood supply, including the incidence and 67 
5 
 
prevalence of TTI, the structure and level of development of blood transfusion services, 68 
and the economic resources available.5  69 
There are several guidelines (GLs) for testing protocols in veterinary medicine. GLs are 70 
generally developed according to the circumstances and needs of each country. No 71 
single GL can ensure absolute blood safety.5 Both American and European GLs aim to 72 
standardize veterinary blood transfusion procedures and to guarantee blood safety.8-10 73 
Additional GLs have been published in Italy to regulate veterinary blood transfusions in 74 
dogs, cats and horses in this country.11-12 However, all these GLs differ in some aspects, 75 
such as the microorganism to be screened or the screening methods.8-10  76 
The aims of this research were i) to evaluate the differences among existing GLs, and ii) 77 
to perform a preliminary investigation on a selected population of feline blood donors 78 
from an Italian blood bank, evaluating how blood safety can be improved using tests 79 
recommended by the different GLs. 80 
 81 
Materials and methods 82 
Comparison of International and National GLs 83 
The main existing GLs for veterinary blood transfusions were compared.8-12 The 84 
European and American GLs were written by a panel of experts, according to evidence-85 
based medicine, even if the level of evidence for each topic was not always explicitly 86 
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declared.8-10 The Italian GL for animal transfusion was written by a panel of experts 87 
commissioned by the Italian Ministry of Health.11,12 88 
 89 
Feline blood donor selection 90 
During the January 2014-January 2015 period, blood samples were collected from cats 91 
enrolled as blood donors at the Blood Bank of the Veterinary Teaching Hospital of the 92 
University of Perugia. Cats were enrolled using the criteria of suitability indicated in the 93 
Italian GL:11,12 body weight ≥5 kg, age 2-8 years, docile character, regularly vaccinated 94 
with core vaccines (feline calicivirus, feline herpesvirus, feline parvovirus) and two 95 
non-core vaccines ( Chlamydia felis, formerly Chlamydophila felis, and feline leukemia 96 
virus, FeLV). Blood donors enrolled in cases of life-threatening emergencies, for which 97 
the national GL recommends fast and restricted screening limited to feline 98 
immunodeficiency virus (FIV), FeLV and Mycoplasma haemofelis, were excluded from 99 
the study. 100 
The owners of cat blood donors were asked for the following information: complete 101 
history, blood collection date, type of owner (staff or client), identification of the 102 
animal, age, gender, weight, breed, origin (adoption from breed or stray cat or purchase 103 
at a pet shop), type of housing (indoor vs outdoor or mixed), cohabitation with other 104 
cats, ectoparasite treatment and frequency, coat (long or short hair), and laboratory test 105 
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results. Travel history was not systematically investigated because initially not included 106 
in the information required.  107 
For each potential donor, before the collection of blood, a careful physical examination, 108 
was performed, with particular emphasis on the presence of fleas or ticks, and biological 109 
samples were collected by a single operator for clinicopathologic screening, consisting 110 
of a complete blood count, typing of blood group, serum chemistry, urinalysis, and 111 
faecal examination.  112 
Blood donation was a voluntary choice by the owners, who signed a written consent 113 
form to authorize blood collection and storage and the use of samples and data for 114 
scientific purposes. Therefore, based on the current regulations of our institutions, the 115 
formal approval of the ethical committee was not needed for this study. 116 
 117 
Sample collection 118 
One ml of blood from each donor was placed into 2 anticoagulated tubes containing 119 
sodium-citrate or EDTA (Ethylene-diamine-tetra-acetic acid) to obtain buffy coat and 120 
plasma, respectively. Three ml of blood were placed in a plain Vacutainer tube (Becton 121 
Dickinson, Milan, Italy) to obtain serum by centrifugation (1000 xg for 10 min). An 122 
aliquot of each sample was stored at -80 °C for further investigations. 123 
 124 
TTI screening 125 
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Serum samples were screened by rapid test using an ELISA for FeLV antigen and FIV 126 
antibodies (SNAP FIV/FeLV Combo test, IDEXX Laboratories) and an 127 
immunochromatographic method for feline coronavirus (FCoV) antibodies (FASTest 128 
FIP, MegaCor Diagnostik).  129 
For each cat a Romanowsky-stained blood smear was microscopically examined to 130 
assess the presence of morphologically detectable microorganisms, with attention given 131 
in particular to haemoplasmas.  132 
DNA and RNA were extracted from 200 µL of both buffy coat and whole blood  133 
samples according to validated protocols (Supplementary Table),13-25 using a 134 
commercial kit for viral RNA and DNA and bacterial DNA (QIAamp cador Pathogen 135 
Mini Kit, Qiagen, Milan, Italy), in accordance with the manufacturer’s instructions. The 136 
concentration and purity of the extracted nucleic acids were quantified using a 137 
NanoDrop® spectrophotometer (NanoDrop 2000, Thermo Fisher Scientific, Milan, 138 
Italy).  139 
Previously published PCR assays, used for the diagnostic activities in the laboratory that 140 
performed the tests, were applied to detect the infectious agents (Supplementary 141 
Table).13-25 Several published PCR protocols were performed in the case of 142 
haemoplasmas13-15 and FeLV18-20 to compare the sensitivity of the assays. In this case, 143 
10-fold dilutions of positive samples were used.  144 
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A PCR targeting the 18S ribosomal RNA gene was used as internal control to rule out 145 
possible PCR inhibitors in the samples.  146 
With regards to FeLV, the PCR product of the expected size was purified with an 147 
extraction kit (Qiaquick PCR purification kit, Qiagen) and directly sequenced on both 148 
strands with the specific primers previously described,20 using a DNA analyzer (ABI 149 
3730, Applied Biosystems) capillary sequencer (Bio-Fab Research srl). The sequences 150 
were assembled and aligned using BioEdit software26 and sequence similarities were 151 
assessed by comparison with the sequences deposited in GenBank using the BLAST 152 
software.27  153 
 154 
Statistical analysis  155 
Chi-square, with Yates’s correction, and Fisher’s exact test were used to compare the 156 
proportions of positive and negative samples, stratified for the data of the animals at the 157 
time of the visit (staff- or client-owner, age, gender, breed, origin, type of housing, 158 
cohabitation with other cats, ectoparasite treatment and frequency, kind of coat), as 159 
most appropriate. Age was analysed by grouping the animals into age categories testing 160 
a cut-off ≤ 3 years. A P value <0.05 was considered statistically significant. EpiInfo28 161 
and OpenEpi29 were used for analysis. 162 
 163 
Results  164 
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Comparison of International and National GLs 165 
Different aspects concerning criteria of suitability, selection and TTI screening for 166 
blood donors are reported in the GLs.8-12 However, all GLs consider FIV, FeLV, and 167 
Mycoplasma haemofelis as the minimum essential level of screening (Tables 1 and 2). 168 
Based on the epidemiological situation of the individual country 14,30-37 and as suggested 169 
by all GLs, Italian GLs were partially integrated with European and American GLs for  170 
increasing blood safety. Accordingly, further TTI were investigated: Candidatus 171 
Mycoplasma haemominutum, Candidatus Mycoplasma turicensis, Anaplasmataceae 172 
family (Anaplasma phagocytophilum and Ehrlichia spp.), Bartonella spp., Babesia spp., 173 
Theileria spp., Cytauxzoon spp., Leishmania donovani sensu lato, and FCoV. In 174 
addition, biomolecular methods were added to the procedures recommended by the 175 
Italian GL.12 176 
 177 
Feline blood donor profiles  178 
Thirty-one cats from 18 different owners were included in the study. Six (19.4%) were 179 
female (3 neutered) and 25 (80.6%) male (15 neutered). The mean age was 4 years 180 
(median 5, range 2-8) and the mean weight 6.23 kg (median 6, range 5-9). Twenty-three 181 
(74.2%) were domestic shorthair, whereas 8 (25.8%) were Maine Coon. Twenty cats 182 
(64.5%) were client-owned and 11 (35.5%) staff-owned, including students of the 183 
veterinary medicine course. Based on the answers received, 22 (71%) cats were adopted 184 
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stray kittens, whereas 9 (29%) were purebred cats. Thirteen (44.8%) cats lived indoors, 185 
whereas 16 (55.2%) had access to the outdoors. Twenty-six (83.8%) lived with other 186 
cats. Only 2 owners performed regular ectoparasite treatments, whereas 25 others 187 
(89.3%) administered the treatments mainly in warm periods, and 1 never administered 188 
ectoparasite treatments. Thirteen cats (46.4%) were long-haired, and 15 (53.6%) short-189 
haired. In three cases the recording of the answers missed to collect information on the 190 
kind of coat and treatment, and in two cases the type of housing.  191 
At least 5 owners travelled with their cats in different areas of southern-central Italy.  192 
No cats had recent illnesses. Physical examination and clinicopathologic screenings 193 
were unremarkable, with all the parameters within the standard reference intervals, and 194 
cats were considered eligible for blood donation. 195 
 196 
TTI screening 197 
All cats were negative using FIV and FeLV rapid tests, whereas 5 (16.1%) were 198 
positive for FCoV antibodies.  199 
Blood smears did not reveal morphologically detectable microorganisms. 200 
Cats were negative using PCR for Anaplasmataceae (Anaplasma spp. and Ehrlichia 201 
spp.), Bartonella spp., Babesia spp., Theileria spp., Cytauxzoon spp., Leishmania 202 
donovani sensu lato and FCoV, whereas haemoplasma DNA was detected in 4 cats 203 
(12.9%) using all the PCR protocols targeting the 16S rRNA gene.13-15 However, the 204 
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nested PCR14 was found to be 10-fold more sensitive than the other PCR protocol 205 
used.13,15 Further specific tests16,17 identified three cats as infected with Candidatus 206 
Mycoplasma haemominutum and one with Mycoplasma haemofelis. The latter cat was 207 
also PCR positive for FeLV provirus using the specific nested PCR protocol,19 but not 208 
with the others protocols used to detect FeLV DNA.18,20 The specific nested protocol19 209 
was at least 10-fold more sensitive than the others.18,20 Sequencing of the positive FeLV 210 
PCR product shared 98%-100% identity with the homologous FeLV region LTR 211 
sequences reported in GenBank (accession nos. AY374218, L25630, M18248, 212 
KP728112). 213 
 214 
Statistical analysis 215 
No statistical association with positivity to the screened microorganisms and the 216 
characteristics of the cats was found.  217 
 218 
Discussion  219 
In this study, Italian GLs were applied to 31 feline candidate blood donors enrolled over 220 
a 1-year period. According to these GLs, these cats were fully eligible as blood donors. 221 
However, based on donor selection criteria or recommendations of other GLs, blood 222 
safety could not be completely guaranteed. Indeed, the enrolled cats, although clinically 223 
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healthy, had risk factors for harbouring TTI and resulted also positive for some 224 
microorganisms included in the other GLs.  225 
All 31 cats were negative using rapid tests for FIV and FeLV. One cat was positive for 226 
FeLV provirus, but only when using the most sensitive PCR protocol. This cat should 227 
be excluded from the donation program, considering that FeLV provirus carriers testing 228 
negative for the p27 antigen may transmit FeLV infection to a naïve recipient via blood 229 
transfusion.38 These results show that the Italian GL would have missed this infected cat 230 
because, as opposed to the other GLs,9,10,39 PCR is not even recommended for detecting 231 
proviral FeLV. Furthermore, the results also raised the issue that the same animal may 232 
be classified eligible or ineligible as a blood donor based on the different PCR assay 233 
that is applied.   234 
Blood smears negative for haemoplasmas cannot exclude infection. The sensitivity of 235 
microscopic analysis is too low to detect haemoplasmas in chronically asymptomatic 236 
cats and does not differentiate the Mycoplasma species.40,41 Using sensitive PCR 237 
protocols, as suggested by European and American GLs and previous studies,2,3,8,10 238 
12.9% of cats were positive, with a prevalence comparable with that of previous studies 239 
on blood donors.37,40,42 This confirms the endemicity of haemoplasma in clinically 240 
healthy cats and the high probability of finding a positive cat even in a limited number 241 
of samples.6,40 All the PCR protocols13-15 identified the positive cats, but the nested 242 
PCR14 was 10-fold more sensitive than the other protocols. This protocol should be 243 
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preferred for its higher sensitivity, since fluctuations in the number of circulating 244 
haemoplasmas may lead to false negative results using less sensitive protocols.41 For the 245 
same reason, TTI screening should always be performed on the same blood collected for 246 
donation: negative results for blood samples collected even few days before the 247 
donation cannot rule out the presence of hemoplasmas in subsequent blood samples 248 
used for transfusion because of the fluctuation in bacteremia. Moreover, considering 249 
that the highest risk of haemoplasma transmission by blood was found within one week 250 
from its collection2 and that the risk in feline blood donation was recently defined non-251 
negligible,37 sensitive PCR tests should be recommended. 252 
Mycoplasma haemofelis, the only species included in the Italian and updated American 253 
GLs, was detected in only one cat, whereas three cats were positive for Candidatus 254 
Mycoplasma haemominutum. The Italian GL recommends temporarily excluding cats 255 
infected by Mycoplasma haemofelis from the donation program until PCR results are 256 
negative, whereas American GLs exclude them permanently, assuming that these cats 257 
may be chronic carriers of Mycoplasma.41,43 The identification of haemoplasma species 258 
is considered optional by the American GL.9 However, four haemoplasma species are 259 
recognized in cats, and their pathogenic significance is debated:40,41,44 hence, the 260 
identification of Mycoplasma species, although time-consuming, may be recommended. 261 
Although not currently recommended by all GLs, the screening of FCoV antibodies 262 
using rapid tests, as is required by the Italian GL, showed a low prevalence of infection 263 
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(16.1%) compared to previous studies in Italian populations.35,45 Furthermore, a specific 264 
nested PCR assay demonstrated that blood samples were negative for FCoV. However, 265 
the European GL10 and a recent study46 advise that seropositive cats should be excluded 266 
from the donor program because it is possible that passively transferred anti-FCoV 267 
antibodies could endanger the recipient, if infected, even if no evident risk of 268 
transmission of FCoV via blood has been demonstrated:46,47,48,49 and no reports of 269 
transmission following blood transfusion have been described until now. On the other 270 
hand, there is no evidence that seropositive cats will develop FIP.9,10 With the shortage 271 
of donor cats already available, the exclusion of FCoV seropositive cats is likely 272 
unnecessary and could cause a relevant reduction in the number of blood donor cats. 273 
Moreover, considering that transitory viremia is possible even in seronegative cats,45,50 274 
FCoV RNA screening of blood collected for donation could be appropriate. 275 
The comparison of analytical sensitivities of the different protocols was limited to 276 
haemoplasmas and FeLV PCR assays. However, this approach would have been 277 
appropriate also for the other tests. Therefore validated and common protocols could be 278 
described and advised by GLs in order to guarantee the same level of accuracy in 279 
detecting TTI blood donors everywhere, as is done for notifiable diseases.51 As in 280 
people, however, test accuracy may be time-consuming and expensive. Otherwise, a 281 
lower level of risk assessment should be accepted by the owner of the recipient by 282 
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written consent, such as in the case of emergency transfusions, as is currently indicated 283 
by all GLs.9,10,12  284 
Accordingly, additional appropriate strategies for selecting “low risk donors” should be 285 
applied to reduce the cost and time of screenings and to guarantee a high level of blood 286 
safety. For example, the use of a questionnaire to identify suitable donors could be an 287 
inexpensive and useful tool. As is already the practice in human medicine, recently both 288 
American and European GLs provided different questionnaires to determine the risk 289 
profile.9,10 However, even if the questionnaire was not available at the time of enrolment 290 
in the study, the owners in the current study were asked specific questions and the 291 
profiles of the donor candidates showed that they had risk factors for harbouring TTI.  292 
All 31 Italian donor cats had at least one TTI-risk characteristic or behavior, such as 293 
access to the outdoors, for which American GL specifically recommends repeated 294 
testing,9 or the irregular ectoparasite treatment performed by 89.3% of the owners. All 295 
GLs advise regular ectoparasite treatments, but the frequency of treatments is not 296 
specified. Monthly ectoparasite prophylaxis was suggested by other studies.3,7 The 297 
owners should be encouraged to carry out ectoparasite prophylaxis correctly, 298 
considering the relevance of this practice in the control of a wide range of vector-borne 299 
diseases. Although travel history was not systematically investigated, at least five 300 
owners travelled with their cats in different areas of southern-central Italy, that are at 301 
risk of some infectious diseases and therefore should be considered at high risk for 302 
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harbouring TTI.33,34 Unfortunately, the small number of cats in this study limited the 303 
statistical power of this study. A higher number of animals could improve the 304 
identification of specific risk factors for TTI in Italy. 305 
The possible exclusion of cats with a TTI risk profile from donor programmes contrasts 306 
with the difficulty of finding a sufficient number of adequate donors, as is confirmed by 307 
the enrolment of only 31 cats in more than 1 year. This makes the rejection of candidate 308 
donors very difficult, even if they have a TTI risk profile. Thus the application of a wide 309 
range of sensitive diagnostic tests should be proposed to verify the actual infectious 310 
status and to guarantee a sufficient number of adequate donors. American and European 311 
GLs recommend that donors with a high risk profile should undergo frequent or 312 
extensive TTI screening.9,10  313 
Another possible action for increasing blood safety that is currently not recommended 314 
by GLs is a recruitment strategy that can identify populations of low TTI-risk donors. 315 
No general recruitment criteria are reported in veterinary medicine, and appropriate 316 
surveys should be taken to identify the best strategy. Laboratory-reared cats could be 317 
considered the ideal donors,6 being negative for all the microorganisms, but enrolment 318 
of these animals is open to possible ethical issues.10 A recent survey on hospitals with 319 
blood bank or transfusion services found that staff-owned cats are the donors enrolled 320 
most frequently, followed by colonies of feline donors and client-owned cats.7 These 321 
sources of donors probably reflect different infection risks. Considering the central role 322 
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of the owner in managing health prophylaxis, determining the lifestyle of cats and 323 
choosing to donate blood, it is possible that informed and motivated owners could be a 324 
key point for safer blood donors that reduces the possible exposure to TTI risk factors.  325 
 326 
Conclusions  327 
Since the GLs recommend different protocols and can classify cats differently as 328 
eligible or ineligible for blood donation, the harmonization of recommendations would 329 
be advisable. This is especially important for the main TTI and for the choice of the 330 
most sensitive screening tests, with possible variations according to local 331 
epidemiological situations. These additional recommendations would improve the 332 
general level of transfusion blood safety. Screening costs and time may be reduced if 333 
appropriate tests are selected. Attention should be put to identify donors that were stray 334 
cats, with irregular or no ectoparasite treatments, travelling, or with outdoor access. The 335 
use of biomolecular method should be recommended, at least in the case of storage in 336 
blood banks, to identify proviral FeLV DNA, considering that rapid test is not 337 
definitively discriminatory, and haemoplasma DNA in blood collected for donation. 338 
Moreover, issues raised by FCoV seropositivity and possible presence of FCoV RNA in 339 
seronegative cats should be further considered. 340 
Finally, appropriate recruitment protocols currently not considered in GLs, educational 341 
courses for owners, the possibility of establishing permanent groups of safe blood 342 
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donors and questionnaire-based risk profiles could improve the identification of suitable 343 
donors with low risk of harbouring TTI, reducing the necessity to perform extensive 344 
screening.  345 
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